Trivium Point Advisory’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $803K | Buy |
7,242
+5,406
| +294% | +$599K | 0.09% | 204 |
|
|
2025
Q1 | $206K | Buy |
+1,836
| New | +$206K | 0.03% | 326 |
|
|
2024
Q3 | – | Sell |
-3,648
| Closed | -$250K | – | 336 |
|
|
2024
Q2 | $250K | Buy |
+3,648
| New | +$250K | 0.04% | 271 |
|
|
2024
Q1 | – | Sell |
-24,771
| Closed | -$2.01M | – | 227 |
|
|
2023
Q4 | $2.01M | Buy |
24,771
+533
| +2% | +$43.2K | 0.49% | 62 |
|
|
2023
Q3 | $1.78M | Buy |
24,238
+1,052
| +5% | +$77.1K | 0.49% | 68 |
|
|
2023
Q2 | $1.79M | Buy |
23,186
+1,514
| +7% | +$117K | 0.48% | 70 |
|
|
2023
Q1 | $1.8M | Buy |
21,672
+551
| +3% | +$45.7K | 0.49% | 68 |
|
|
2022
Q4 | $1.86M | Buy |
21,121
+2,876
| +16% | +$253K | 0.54% | 65 |
|
|
2022
Q3 | $1.19M | Buy |
18,245
+7,624
| +72% | +$495K | 0.37% | 89 |
|
|
2022
Q2 | $666K | Buy |
+10,621
| New | +$666K | 0.2% | 131 |
|